Comparative

OMIA group 2131

Methaemoglobinaemia, CYB5R3-related

The chain

From the animal disease to the drugs. The page shows what each step found and where the chain stopped. It does not say whether the animal is a model of a human disease.

  1. Animal disease

    Reached

    OMIA records it in 2 species entries marked as a defect.

  2. Human disease

    Reached

    1 Mondo disease.

  3. Human gene

    Reached

    1 human gene.

  4. Target evidence

    Reached

    1 Open Targets association, with a best score of 0.73.

  5. Drugs

    Stopped here

    No ChEMBL drug acts on a human gene of the group's target evidence.

The chain stopped at Drugs: No ChEMBL drug acts on a human gene of the group's target evidence.

Natural-model score

How complete and how well supported the chain to each human disease is, out of 100, by stated rules. It does not say that the animal is a validated model of the human disease. How the score works.

Part Computed from Points
Target evidence Open Targets score of 0.73 25.6 of 35
Drugs No drug has been tested for this disease, and none acts on its genes 0.0 of 25
Ortholog One to one ortholog 20.0 of 20
Both routes Both routes found this disease 10.0 of 10
Species 2 naturally occurring species entries marked as a defect 7.0 of 10

Species

The chain follows only the species entries that OMIA marks as a defect.

Species Scientific name OMIA entry A defect
dog Canis lupus familiaris OMIA:002131-9615 Yes
domestic cat Felis catus OMIA:002131-9685 Yes

Genes

Each gene OMIA records for a species entry, and the human gene it reaches through Ensembl's orthologs.

Species Animal gene Human gene Ortholog
dog CYB5R3 cytochrome b5 reductase 3 NCBI Gene 474479 CYB5R3 Ensembl one to one
domestic cat CYB5R3 NCBI Gene 101091382 Ensembl does not know this NCBI Gene identifier.

Human diseases

Two routes lead from an OMIA group to a Mondo human disease: OMIA's own Mondo link, and the group's OMIM numbers through Mondo's cross-references.

Mondo disease Name Found by
MONDO:0009606 methemoglobinemia due to deficiency of methemoglobin reductase Both routes

Target evidence

Each Open Targets association between one of the group's human genes and one of its human diseases, with its overall score and the score for each kind of evidence.

Human gene Human disease Score Evidence Kinds of evidence
CYB5R3 methemoglobinemia due to deficiency of methemoglobin reductase 0.73 37 Genetic association 0.88 Genetic literature 0.81 Literature 0.09

Drugs

No ChEMBL drug acts on a human gene of the group's target evidence.